Quizartinib for Newly Diagnosed <i>FLT3</i> -Internal Tandem Duplication–Negative AML

M Motoharu Shibusawa (Motoharu Shibusawa, MD, Sanaikai General Hospital, Saitama, Japan; and Tetsuya Tanimoto, MD, Medical Governance Research Institute, Tokyo, Japan) T Tetsuya Tanimoto (Motoharu Shibusawa, MD, Sanaikai General Hospital, Saitama, Japan; and Tetsuya Tanimoto, MD, Medical Governance Research Institute, Tokyo, Japan)

Article Details

Volume / Issue Vol. 44, Issue 17
Published June 10, 2026
Pages 1648-1648
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (2)

M

Motoharu Shibusawa

Motoharu Shibusawa, MD, Sanaikai General Hospital, Saitama, Japan; and Tetsuya Tanimoto, MD, Medical Governance Research Institute, Tokyo, Japan

T

Tetsuya Tanimoto

Motoharu Shibusawa, MD, Sanaikai General Hospital, Saitama, Japan; and Tetsuya Tanimoto, MD, Medical Governance Research Institute, Tokyo, Japan